CytoMed Therapeutics Ltd

GDTC

Company Profile

  • Business description

    CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

  • Contact

    1 Commonwealth Lane
    No. 08-22 One Commonwealth
    Singapore149544
    SGP

    T: +65 62507738

    https://w2.cytomed.sg

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    42

Stocks News & Analysis

stocks

Higher distribution from ASX income share

Solid long-term outlook.
stocks

Are ASX REITs the better way to own property?

Cheap valuations, strong yields and a changing Aussie property landscape.
stocks

Cheap Dividend Aristocrat has Fair Value raised after earnings

Dividend forecasts raised after balance sheet regains strength.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,279.003.00-0.03%
CAC 408,597.0439.75-0.46%
DAX 4026,395.7144.60-0.17%
Dow JONES (US)53,732.41107.58-0.20%
FTSE 10010,739.0311.08-0.10%
HKSE25,453.23336.381.34%
NASDAQ26,729.1673.86-0.28%
Nikkei 22569,220.25506.450.74%
NZX 50 Index13,721.98132.40-0.96%
S&P 5007,785.760.000.00%
S&P/ASX 2009,073.206.10-0.07%
SSE Composite Index3,982.6555.481.41%

Market Movers